Clinical Trial Update: Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing the addition of Paclitaxel to a high-dose chemotherapy regimen for high-risk breast cancer in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: St. Louis University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN